Best Growth Stocks To Buy Today – December 2025
Five growth stocks spanning tech and healthcare sectors show compelling growth trajectories, with annual EPS projections ranging from 18% to 60% through 2030. Nvidia dominates the AI semiconductor space, buoyed by 35%+ annual EPS growth forecasts and 39 Strong Buy ratings. Demand for its data center and machine learning chips remains insatiable.
Amazon’s AWS cloud services drive 25% yearly revenue growth potential, accounting for over 60% of company profits. Forty-five analysts endorse it as a Buy or Strong Buy. Meanwhile, CRISPR Therapeutics pioneers gene therapy with Casgevy for blood disorders, though pipeline risks prompt 35% of analysts to maintain Hold ratings despite 50%+ EPS growth potential.
Viking Therapeutics enters the $100B+ obesity market with oral weight-loss drug VK2735, attracting 14 Strong Buy ratings and 60%+ EPS growth projections. The convergence of AI, cloud computing, and biotech innovation underscores these picks.